Integra LifeSciences Announces Launch of Integra(R) Flowable Wound Matrix in Europe for Diabetic Foot and Leg Ulcers

Integra LifeSciences Announces Launch of Integra(R) Flowable Wound Matrix in Europe for Diabetic Foot and Leg Ulcers

[at noodls] – PLAINSBORO, N.J., Jan. 18, 2013 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received European CE Mark Certification for its Integra® Flowable … more

View todays social media effects on IART

View the latest stocks trending across Twitter. Click to view dashboard

See who Integra is hiring next, click here to view

Share this post